|Articles|October 15, 2013
Structural Forces Impacting the Pharmaceutical Industry
Patrick Lindsay, president of UBC sits down with Editorial Director William Looney to discusses the issues UBC confronts as it offers support services to pharmaceutical companies
Advertisement
Patrick Lindsay, president of UBC sits down with Editorial Director Bill Loony to discusses the issues UBC confronts as it offers support services to pharmaceutical companies.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics
2
Pharma Funding Roundup: QuantX Biosciences, Pandorum Technologies Complete Series B Financing Rounds
3
Articulating the Long-Term Value of AI-Powered Approaches
4
M&A Acceleration: Q&A with Subin Baral
5